PHOENIX, Ariz. — October 4, 2022 — The Translational Genomics Research Institute, Part of City of Hope, and Stingray Therapeutics, Inc. of Dallas and Houston, Texas today announced a Small Business Innovation Research (SBIR) accelerated direct to phase II award of $2 Million. The NIH award, known as America’s Seed Fund, provides support to early-stage businesses to bring scientific innovations from bench to bedside.Continue reading